FDA Updates CLIAC On Diagnostic Guidance Pipeline, Co-Development Trends
This article was originally published in The Gray Sheet
Executive Summary
FDA's drug center increasingly consults with the Office of In Vitro Diagnostic Device Evaluation & Safety regarding in vitro diagnostics used to support drug clinical trials, according to OIVD staffer Jean Cooper